The Mary Jane Society

Innovating Cannabis Podcast

Business EN ↓ 200 episodes

Welcome to the Innovating Cannabis Podcast, where you will meet the people breaking barriers in the cannabis industry, both locally, nationally, and internationally, with a focus on business, entrepreneurship, cultivation, manufacturing, retail, brands, science, and policy. Get in touch with pam@InnovatingCannabisPodcast.com

Author

The Mary Jane Society

Category

Business

Latest episode

Jul 3, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

200_ The FDA Pathway for CBN: What It Means for Cannabis Supplements 03.07.2026

Alleh Lindquist is the CEO and co-founder of FloraWorks, a cannabinoid innovation company focused on bringing science-backed minor cannabinoids into the mainstream.  As a leading supplier of hemp-derived cannabinoids to manufacturers, FloraWorks has been at the forefront of CBN research and commercialization, including helping popularize CBN as an ingredient for sleep products.  Today, the company...

199_ Restoring Volatile Compounds with True Terpenes Daniel Cook 26.06.2026

Much of the complexity of the cannabis plant stems from its aromatic compounds beyond terpenes, such as sesquiterpenes, aldehydes, esters, and ketones, and sulfur compounds, which are difficult to preserve during cultivation and extraction. In this episode, I sit down with Daniel Cook, CEO of True Terpenes, to discuss the company's Headstash product line and its ability to preserve volatiles and r...

198_ Is Peru the Next Hot Market for US Cannabis Brands? 14.06.2026

  Is Peru the Next Hot Market for US Cannabis Brands? If you work with hemp, the market is about to open for import/export operations. Peru's medical cannabis framework dates to 2017, when cannabis was legalized for medicinal use, scientific research, and pharmaceutical production. Patient associations gained cultivation rights in 2021, though the market remained limited — by mid-2025, official re...

197_ How QRLogix Is Taking the Pain Out of METRC's Retail ID Tags 07.06.2026

New York retailers have been among the most vocal critics of METRC's required Retail ID tags — another layer in the state's track-and-trace system that adds real labor and cost burdens for operators. QRLogix , a labeling software company with roots in the medical industry, has adapted its technology to work within the METRC framework and eliminate that burden. Here to explain how it works is David...

196_ Checking in on the DC Market with District Cannabis 31.05.2026

District Cannabis was founded in 2015 as a cultivation company and has steadily expanded its footprint over the past decade, adding manufacturing capabilities and building one of the region's most sustainable cannabis brands. In 2024, the company completed a major expansion, launching a retail location in Washington, D.C., while also growing its cultivation, manufacturing, and retail operations in...

195_ Inside the Bellrock Turnaround with Joe Bayern 18.05.2026

Episode 195_ Inside the Bellrock Turnaround with Joe Bayern Before entering cannabis in 2019, Joe Bayern spent more than 25 years in C-suite leadership across some of the biggest names in beverages, helping drive major turnarounds, global strategy, and brand-building at Snapple, Cadbury Schweppes, Dr Pepper Snapple Group, and Voss Water. He entered cannabis after recognizing the potential of early...

194_ Understanding Your True Manufacturing COGS 11.05.2026

Understanding the true cost of cultivating and manufacturing a cannabis product is incredibly difficult without the right tracking tools. Labor, yield loss, compliance, packaging, and processing inefficiencies can all quietly erode profitability without operators ever fully realizing it. That lack of visibility creates major challenges not only for manufacturers trying to scale efficiently, but al...

193_ Is Georgia’s Medical Cannabis Model the Blueprint Other States Should Follow? 03.05.2026

Georgia legalized medical cannabis in late 2015, but the market itself didn't officially launch until around 2020. As a highly restricted, limited-license state, Georgia allows only six vertically integrated operators. What makes Georgia especially unique is its distribution model: patients can access products not only through dispensaries, but also through pharmacies—an approach similar to the Eu...

192_ Preserving India's Cannabis Heritage with Vikramm Mitra 27.04.2026

India has one of the longest and most deeply rooted relationships with cannabis of any culture, and is home to some of the most prized landrace cultivars in the world. Vikramm Mitra, the co-founder of Delta Botanicals, is working to preserve that legacy and bring India into the global cannabis market. In January, Delta Botanicals received the first agricultural grant ever awarded by the Indian gov...

191_ How Curaleaf Designs the Next Generation of Cannabis Products 22.04.2026

Jessie Kater, SVP of Innovation, R&D, and Technical Manufacturing at Curaleaf, brings a deeply technical background to the cannabis industry. Trained in chemical engineering and toxicology, he began his career in pharmaceuticals, went on to work in R&D for a defense contractor, and spent time in biotech before ultimately making the move into cannabis. He also founded his own R&D testing lab prior...

190_Where Cannabis Brands Struggle in Retail Execution 17.04.2026

As the cannabis industry faces tighter margins and harder-to-find profits, many businesses are struggling not just to grow, but to survive. This year, operators are shifting focus. Instead of chasing expansion, they are being forced to rethink how they grow and, more importantly, how they operate efficiently. Today, our guest is Matt Morea, co-founder of PrizmGPS , a company focused on what happen...

189_ MMJ Holdings Moves Ahead with FDA Approved Botanical Drug Pathway 09.04.2026

Today, we're joined by Duane Boise, CEO of MMJ Holdings, a biopharmaceutical company advancing cannabis-derived medicines through the FDA's botanical Drug Development Pathway. MMJ has received Orphan drug designation for Huntington's disease and multiple sclerosis, and its cannabis-derived soft-gel formulations are now preparing to enter phase 2 clinical trials, helping pave the way for a new era...

188_Operating in Missouri with Curio Wellness 02.04.2026

Curio Wellness was founded by father-and-daughter team Michael and Wendy Bronfein. Michael built his career in the supermarket industry before launching his own chain of pharmacies, eventually bringing that experience into Maryland's medical cannabis market in 2015. Since then, Curio has grown into a vertically integrated company with GMP-certified operations in Maryland and Missouri, franchise pa...

187_ AI and Cannabis Medicine with Hemant Kumar Bid 27.03.2026

Today's guest is Dr. Hemant Kumar Bid , a scientist, educator, and consultant at the forefront of biotechnology, medical cannabis, and artificial intelligence. Dr. Bid serves as Program Director for the Master of Science in Biotechnology with a concentration in Medical Cannabis at Morehouse School of Medicine — one of the only programs of its kind offered entirely online.   His academic foundation...

186_ Trade Show Strategy and Cannabis Industry Insights With George Jage 21.03.2026

Trade show season for 2026 is officially underway.  I’ll be heading to MJ Unpacked , taking place May 5–7 in Atlantic City, New Jersey.  I recently sat down with co-founder George Jage—someone many of you already know from his long track record in the trade show world, including his role in helping scale MJBizCon in the early days.  In this conversation, we go beyond the typical event preview and...

185_ Crunching Numbers With Sax Accounting 18.03.2026

Allison Kirchhofer is the Director of the Cannabis Division at Sax Accounting , where she leads a team of CPAs serving operators across multiple states. She has also worked closely with businesses in New York.s turbulent adult-use rollout, helping them manage compliance, tax strategy, and financial infrastructure in one of the country's most closely watched markets.   Prior to joining Sax, Allison...

184_ How's the Nevada Cannabis Market Doing? 09.03.2026

Kema Ogden was one of the early pioneers of Nevada’s legal cannabis industry. In 2015, she helped open one of the state’s first medical dispensaries, laying the foundation for what would become the Top Notch THC brand. Since then, she and her partners have expanded to multiple adult-use locations across Nevada, building a loyal customer base in one of the country’s most competitive cannabis market...

183_ How a Wisconsin Spirits Distiller Is Breaking Into THC Beverages 03.03.2026

River Falls, Wisconsin, is home to Tattersall Distilling, a nationally recognized craft spirits producer whose portfolio is distributed across 25 states. Known for sourcing locally and crafting spirits infused with botanicals and functional ingredients, Tattersall has built a reputation on flavor innovation and ingredient integrity.  Co-founder Jon Kreidler joins the show to discuss the company's...

182 Jeff Rawson's Mission to Protect Cannabis Consumers 25.02.2026

Jeff Rawson founded the nonprofit Institute of Cannabis Science while serving as a postdoctoral researcher in chemistry at Harvard University. He conducts scientific research, investigative reporting, and regulatory reviews, and provides subject-matter expertise in cannabis testing.  Jeff serves on the ASTM D37 Committee on Cannabis and is involved with ACIL, which honored him with the 2024 Presto...

181_Updates on the Ohio Market with Law Firm, Ice Miller 23.02.2026

Today, we examine the Ohio cannabis market with our guests, attorneys John Oberle and Greg May from Ice Miller. We discuss the latest referendum effort led by Ohioans for Cannabis Choice, which seeks to repeal key components of a bill the governor recently signed to scale back the state's voter-approved cannabis law and ban the sale of consumable hemp products outside of licensed cannabis dispensa...

180_ California Has a New Director of Cannabis Control 18.02.2026

Clint Kellum brings nearly 20 years of public service experience with the State of California, where he specialized in budget and policy work at the California Department of Finance. He joined the California Dept of Cannabis Control about five years ago as Chief Operating Officer, and was recently appointed Director, where he now leads the agency’s operations and helps shape the future of cannabis...

179_ The Latest CBD Scientific Research from Western Washington University 16.02.2026

Josh Kaplan is the Associate Professor of Behavioral Neuroscience at Western Washington University. His research focuses on optimizing CBD-based medicine for pediatric conditions (e.g., epilepsy, autism spectrum disorder, exposure to early life stress). They use mouse models to probe the effects of CBD and terpenes at the behavioral, molecular, and electrophysiological levels.   They can observe t...

178_Building The German Cannabis Marketplace 08.02.2026

Dr. Julian Wichmann is a board-certified radiologist and the co-founder and CEO of Bloomwell, the first cannabis telemedicine platform to launch in Germany—and a model the U.S. should pay close attention to.   We dive into the current state of Germany’s cannabis market, the challenges of building a telemedicine blueprint from the ground up, how medical cannabis is revitalizing German pharmacies, a...

177_ BIPOCann Leads the Way for Business Incubators 06.02.2026

Ernest Toney joins us today. He is the founder of BIPOCANN , a Colorado-based nonprofit that provides business guidance to social equity entrepreneurs looking to start and scale cannabis businesses. According to a survey released by economist Beau Whitney, only 27.3 percent of U.S. cannabis businesses are profitable. Another 40.6 percent are breaking even, while 32.2 percent are operating at a los...

176: Taking Cannabis Consumption to a New Level 29.01.2026

Today, we are joined by Chris Emerson, who earned his PhD in small-molecule chemistry and completed his postdoctoral research at Stanford University before bringing his scientific rigor to the cannabis industry. He’s now the CEO and Chief Scientist of Level, and was one of the first to introduce cannabis in a precise, pill-based format. At Level, the team is laser-focused on developing effect-base...

Listen to the Innovating Cannabis Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.